Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elisabeth Latour is active.

Publication


Featured researches published by Elisabeth Latour.


Ophthalmic Research | 1988

Oxidative stress and lens opacity: an overall approach to screening anticataractous drugs.

Gérard Tissié; Véronique Guillermet; Elisabeth Latour; Claude Coquelet; Claude Bonne

Since oxidative stress is a well substantiated hypothesis of cataract pathogenesis, screening was performed in acellular systems in order to select scavengers of reactive oxygen species; the selected compounds are at present being tested in lens culture and in animal models.


Advances in Experimental Medicine and Biology | 1990

Singlet Oxygen-Induced Damage to Rat Lenses in Vitro: Protection by Anisyldithiolthione

Gérard Tissié; Elisabeth Latour; Claude Coquelet; Claude Bonne

Oxidation is now recognized as being the major process involved m lens changes associated with cataract development (1). Visible light and near UV (300–400 nm) could be an important source of oxygen reactive species, in particular singlet oxygen Photosensitizers such as rihoiiavin and N-formylkynurenine have been shown to be present in the lens (2) Singlet oxygen provokes in vitro the same alterations in lens cristallins as those observed in aging and cataracts (3, 4) This reactive species also produces an impairment of transport systems in the rat lens (5). Furthermore, it is a powerful inducer of lipid peroxidation considered as an initiating event in cataract formation (6).


Advances in Experimental Medicine and Biology | 1990

Free Radical Scavenging Capacity and Anti-Inflammatory Activity of CBS-113 A

Claude Bonne; Gérard Tissié; Hoa Ngo Trong; Elisabeth Latour; Claude Coquelet

CBS-113 A, 2-(2-Hydroxy-4-methylphenyl)aminothiazole hydrochloride, is a dual inhibitor of cyclooxygenase and lipoxygenase with topical anti-inflammatory activity (1). This compound is also a powerful free radical (FR) scavenger. The aim of this study was to design a pharmacological model of ocular inflammation for determining the respective contribution of the FR scavenging capacity and the inhibition of icosanoid production to the anti-inflammatory activity of this compound.


Archive | 1987

Process and pharmaceutical compositions for the treatment of glaucoma

Claude Bonne; Claude Coquelet; Elisabeth Latour


Archive | 1999

Ophthalmic composition comprising a beta -blocker

Florence Maurin; Elisabeth Latour; Claude Coquelet


Archive | 1990

Paracetamol-based pharmaceutical composition

Claude Coquelet; Claude Bonne; Elisabeth Latour


Archive | 1996

Eye lotion in particular for dry eye treatment

Florence Maurin; Elisabeth Latour; Claude Coquelet


Archive | 1996

Pharmaceutical compositions based on mequitazine

Claude Coquelet; Elisabeth Latour; Florence Maurin


Archive | 1990

Pharmaceutical composition with a paracetamol base.

Claude Coquelet; Claude Bonne; Elisabeth Latour


Archive | 1999

OPHTHALMIC COMPOSITION COMPRISING A β-BLOCKER

Florence Maurin; Elisabeth Latour; Claude Coquelet

Collaboration


Dive into the Elisabeth Latour's collaboration.

Top Co-Authors

Avatar

Claude Bonne

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar

Gérard Tissié

University of Montpellier

View shared research outputs
Researchain Logo
Decentralizing Knowledge